ArticleEvidence-based complementary and alternative medicine : eCAM2022

Pan-Cancer Analysis of BUB1B/hsa-miR-130a-3p Axis and Identification of Circulating hsa-miR-130a-3p as a Potential Biomarker for Cancer Risk Assessment.

Xiaoxia Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.